MedPath

Olfactory stimulation on apnea of prematurity

Phase 2
Conditions
apnea.
Other apnoea of newborn
Registration Number
IRCT2015042821982N1
Lead Sponsor
Vice Chancellor for research of Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Babies less than 32 weeks with weight less than 32 weeks who developed immature apnea and specialists distinguish immature apnea and started Methyl Xanthine for treatment and also 4-8 hours after receiving Methyl Xanthine are started into the study.
Exclusion criteria: Distinguished apnea due to other reasons including acute infections; congenital heart illnesses; anemia (Hb<10); consumers of sedative medicines; hypoglycemia; hypocalcaemia are removed and babies with brain hemorrhage than grade 1; leukomalacia preventricular; patent dactus arterious; chromosomal disorders; brain disorders and babies with allergy to vanilla smell are not introduced into the study. During the study, babies with Hemoglobin less than 10 and babies with apnea more than 3 are connected to cpap within one hour and are out of the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oxygen saturation. Timepoint: First, second and third day after birth in both control and experimental groups. Method of measurement: As percentage using a pulse oximeter.;Heart rate. Timepoint: First, second and third day after birth in both control and experimental groups. Method of measurement: as beat using pulse oximetry.;Episods of apnea. Timepoint: First, second and third day after birth in both control and experimental groups. Method of measurement: as beat using pulse oximetry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath